Expression level and DNA methylation status of glutathione-S-transferase genes in normal murine prostate and TRAMP tumors

Cory K. Mavis, Shannon R. Morey Kinney, Barbara A. Foster, Adam R Karpf

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

BACKGROUND. Glutathione-S-transferase (Gst) genes are downregulated in human prostate cancer, and GSTP1 silencing is mediated by promoter DNA hypermethylation in this malignancy. We examined Gst gene expression and Gst promoter DNA methylation in normal murine prostates and Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) tumors. METHODS. Primary and metastatic tumors were obtained from TRAMP mice, and normal prostates were obtained from strain-matched WT mice (n = 15/group). Quantitative real-time RT-PCR was used to measure GstA4, GstK1, GstM1, GstO1, and GstP1 mRNA expression, and Western blotting and immunohistochemical staining was used to measure GstM1 and GstP1 protein expression. Mass ARRAY Quantitative Methylation Analysis was used to measure DNA methylation of the 5′ CpG islands of GstA4, GstK1, GstM1, GstO1, and GstP1. TRAMP-C2 cells were treated with the epigenetic remodeling drugs decitabine and trichostatin A (TSA) alone and in combination, and Gst gene expression was measured. RESULTS. Of the genes analyzed, GstM1 and GstP1 were expressed at highest levels in normal prostate. All five Gst genes showed greatly reduced expression in primary tumors compared to normal prostate, but not in tumor metastases. Gst promoter methylation was unchanged in TRAMP tumors compared to normal prostate. Combined decitabine + TSA treatment significantly enhanced the expression of 4/5 Gst genes in TRAMP-C2 cells. CONCLUSIONS. Gst genes are extensively downregulated in primary but not metastatic TRAMP tumors. Promoter DNA hypermethylation does not appear to drive Gst gene repression in TRAMP primary tumors; however, pharmacological studies using TRAMP cells suggest the involvement of epigenetic mechanisms in Gst gene repression.

Original languageEnglish (US)
Pages (from-to)1312-1324
Number of pages13
JournalProstate
Volume69
Issue number12
DOIs
StatePublished - Sep 1 2009

Fingerprint

DNA Methylation
Glutathione Transferase
Transgenic Mice
Prostate
Adenocarcinoma
Genes
Neoplasms
decitabine
trichostatin A
Epigenomics
Methylation
Down-Regulation
Gene Expression
CpG Islands
DNA
Real-Time Polymerase Chain Reaction
Prostatic Neoplasms
Western Blotting
Pharmacology
Staining and Labeling

Keywords

  • DNA methylation
  • Glutathione-S-transferase
  • Prostate cancer
  • TRAMP

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this

Expression level and DNA methylation status of glutathione-S-transferase genes in normal murine prostate and TRAMP tumors. / Mavis, Cory K.; Morey Kinney, Shannon R.; Foster, Barbara A.; Karpf, Adam R.

In: Prostate, Vol. 69, No. 12, 01.09.2009, p. 1312-1324.

Research output: Contribution to journalArticle

Mavis, Cory K. ; Morey Kinney, Shannon R. ; Foster, Barbara A. ; Karpf, Adam R. / Expression level and DNA methylation status of glutathione-S-transferase genes in normal murine prostate and TRAMP tumors. In: Prostate. 2009 ; Vol. 69, No. 12. pp. 1312-1324.
@article{8d034aa898774f30aaedcf0fcae1c5b5,
title = "Expression level and DNA methylation status of glutathione-S-transferase genes in normal murine prostate and TRAMP tumors",
abstract = "BACKGROUND. Glutathione-S-transferase (Gst) genes are downregulated in human prostate cancer, and GSTP1 silencing is mediated by promoter DNA hypermethylation in this malignancy. We examined Gst gene expression and Gst promoter DNA methylation in normal murine prostates and Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) tumors. METHODS. Primary and metastatic tumors were obtained from TRAMP mice, and normal prostates were obtained from strain-matched WT mice (n = 15/group). Quantitative real-time RT-PCR was used to measure GstA4, GstK1, GstM1, GstO1, and GstP1 mRNA expression, and Western blotting and immunohistochemical staining was used to measure GstM1 and GstP1 protein expression. Mass ARRAY Quantitative Methylation Analysis was used to measure DNA methylation of the 5′ CpG islands of GstA4, GstK1, GstM1, GstO1, and GstP1. TRAMP-C2 cells were treated with the epigenetic remodeling drugs decitabine and trichostatin A (TSA) alone and in combination, and Gst gene expression was measured. RESULTS. Of the genes analyzed, GstM1 and GstP1 were expressed at highest levels in normal prostate. All five Gst genes showed greatly reduced expression in primary tumors compared to normal prostate, but not in tumor metastases. Gst promoter methylation was unchanged in TRAMP tumors compared to normal prostate. Combined decitabine + TSA treatment significantly enhanced the expression of 4/5 Gst genes in TRAMP-C2 cells. CONCLUSIONS. Gst genes are extensively downregulated in primary but not metastatic TRAMP tumors. Promoter DNA hypermethylation does not appear to drive Gst gene repression in TRAMP primary tumors; however, pharmacological studies using TRAMP cells suggest the involvement of epigenetic mechanisms in Gst gene repression.",
keywords = "DNA methylation, Glutathione-S-transferase, Prostate cancer, TRAMP",
author = "Mavis, {Cory K.} and {Morey Kinney}, {Shannon R.} and Foster, {Barbara A.} and Karpf, {Adam R}",
year = "2009",
month = "9",
day = "1",
doi = "10.1002/pros.20976",
language = "English (US)",
volume = "69",
pages = "1312--1324",
journal = "Prostate",
issn = "0270-4137",
publisher = "Wiley-Liss Inc.",
number = "12",

}

TY - JOUR

T1 - Expression level and DNA methylation status of glutathione-S-transferase genes in normal murine prostate and TRAMP tumors

AU - Mavis, Cory K.

AU - Morey Kinney, Shannon R.

AU - Foster, Barbara A.

AU - Karpf, Adam R

PY - 2009/9/1

Y1 - 2009/9/1

N2 - BACKGROUND. Glutathione-S-transferase (Gst) genes are downregulated in human prostate cancer, and GSTP1 silencing is mediated by promoter DNA hypermethylation in this malignancy. We examined Gst gene expression and Gst promoter DNA methylation in normal murine prostates and Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) tumors. METHODS. Primary and metastatic tumors were obtained from TRAMP mice, and normal prostates were obtained from strain-matched WT mice (n = 15/group). Quantitative real-time RT-PCR was used to measure GstA4, GstK1, GstM1, GstO1, and GstP1 mRNA expression, and Western blotting and immunohistochemical staining was used to measure GstM1 and GstP1 protein expression. Mass ARRAY Quantitative Methylation Analysis was used to measure DNA methylation of the 5′ CpG islands of GstA4, GstK1, GstM1, GstO1, and GstP1. TRAMP-C2 cells were treated with the epigenetic remodeling drugs decitabine and trichostatin A (TSA) alone and in combination, and Gst gene expression was measured. RESULTS. Of the genes analyzed, GstM1 and GstP1 were expressed at highest levels in normal prostate. All five Gst genes showed greatly reduced expression in primary tumors compared to normal prostate, but not in tumor metastases. Gst promoter methylation was unchanged in TRAMP tumors compared to normal prostate. Combined decitabine + TSA treatment significantly enhanced the expression of 4/5 Gst genes in TRAMP-C2 cells. CONCLUSIONS. Gst genes are extensively downregulated in primary but not metastatic TRAMP tumors. Promoter DNA hypermethylation does not appear to drive Gst gene repression in TRAMP primary tumors; however, pharmacological studies using TRAMP cells suggest the involvement of epigenetic mechanisms in Gst gene repression.

AB - BACKGROUND. Glutathione-S-transferase (Gst) genes are downregulated in human prostate cancer, and GSTP1 silencing is mediated by promoter DNA hypermethylation in this malignancy. We examined Gst gene expression and Gst promoter DNA methylation in normal murine prostates and Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) tumors. METHODS. Primary and metastatic tumors were obtained from TRAMP mice, and normal prostates were obtained from strain-matched WT mice (n = 15/group). Quantitative real-time RT-PCR was used to measure GstA4, GstK1, GstM1, GstO1, and GstP1 mRNA expression, and Western blotting and immunohistochemical staining was used to measure GstM1 and GstP1 protein expression. Mass ARRAY Quantitative Methylation Analysis was used to measure DNA methylation of the 5′ CpG islands of GstA4, GstK1, GstM1, GstO1, and GstP1. TRAMP-C2 cells were treated with the epigenetic remodeling drugs decitabine and trichostatin A (TSA) alone and in combination, and Gst gene expression was measured. RESULTS. Of the genes analyzed, GstM1 and GstP1 were expressed at highest levels in normal prostate. All five Gst genes showed greatly reduced expression in primary tumors compared to normal prostate, but not in tumor metastases. Gst promoter methylation was unchanged in TRAMP tumors compared to normal prostate. Combined decitabine + TSA treatment significantly enhanced the expression of 4/5 Gst genes in TRAMP-C2 cells. CONCLUSIONS. Gst genes are extensively downregulated in primary but not metastatic TRAMP tumors. Promoter DNA hypermethylation does not appear to drive Gst gene repression in TRAMP primary tumors; however, pharmacological studies using TRAMP cells suggest the involvement of epigenetic mechanisms in Gst gene repression.

KW - DNA methylation

KW - Glutathione-S-transferase

KW - Prostate cancer

KW - TRAMP

UR - http://www.scopus.com/inward/record.url?scp=67650895683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650895683&partnerID=8YFLogxK

U2 - 10.1002/pros.20976

DO - 10.1002/pros.20976

M3 - Article

VL - 69

SP - 1312

EP - 1324

JO - Prostate

JF - Prostate

SN - 0270-4137

IS - 12

ER -